You know zilch. There’s no public facing evidence that Specials has generated any more survivors than the normal 7%+ @ 5 years SOC. The lack of enrollment and lack of awareness actually suggest the opposite.
>>With DCVax-L, we already know the answer. It has been safely used in the UK for over five years under physician-supervised conditions. It has long-term survivors. It has peer-reviewed results. The data is real. The patients are real. And the hope it brings is real.
Market Data 
Markets 
AI
